Drs Ursula A. Matulonis and Katherine Fuh discuss the molecular classification and genetics of endometrial cancer as well as when to rebiopsy, research updates, and what's to come in the future.

This study presents valuable findings on the increased prevalence of pain in women with polycystic ovary syndrome and its relationship to health outcomes. The evidence supporting the conclusions is ...

ER+/PR+ breast cancer, common and hormone-responsive, offers a better prognosis and is key in treatment research advancements ...

Diagnosis of PDB is a combination of clinical evaluation, imaging and histopathological assessment. If an underlying cancer ...

Ovarian cancer (OC), the most lethal gynecological malignancy, is the fifth leading cause of cancer-related death in women.

However, the cell heterogeneity of chondrocytes in human articular cartilage is still not well defined, which hinders understanding of the pathogenesis of OA. This research, published in the Genes ...

If your OB/GYN tells you that you have ovarian cysts, it might make you worry about ovarian cancer. But even though these two conditions can bring on similar symptoms, they’re very different ...

Because no effective screening test currently exists, 70% of people with ovarian cancer are diagnosed at advanced stages, when chances of cure are poor. Around 60% to 90% of people with stage one or ...

Cancer cells may cause body odors, but not odors that most people will notice. While some studies show dogs may be able to detect cancer smells, researchers are exploring the possibility of detecting ...

Epithelial ovarian cancer is the most common type of ovarian cancer. About 90 out of 100 tumours of the ovary (90%) are epithelial. Epithelial ovarian cancer starts in the surface layer covering the ...